title: Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
authors.affiliation: Department of Surgery, University of Leicester, Leicester General Hospital, United Kingdom.
authors.forename: E O
authors.initials: EO
authors.lastname: Kehinde
authors.forename: T
authors.initials: T
authors.lastname: Wheatley
authors.forename: J
authors.initials: J
authors.lastname: Feehally
authors.forename: M L
authors.initials: ML
authors.lastname: Nicholson
authors.forename: P S
authors.initials: PS
authors.lastname: Veitch
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
mesh_terms: D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D009543:Nifedipine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors; D014481:United States
chemical_list: D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D009543:Nifedipine; D001379:Azathioprine